UiPath . Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
UiPath . Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2022-01-31 | 2021-10-31 | 2021-07-31 | 2021-04-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | ||||||||||||||||||
net income | 1,584,000 | -22,555,000 | 51,794,000 | -10,655,000 | -86,097,000 | -28,736,000 | 33,916,000 | -31,537,000 | -60,361,000 | -31,901,000 | -27,689,000 | -57,724,000 | -120,378,000 | -122,561,000 | -63,110,000 | -122,787,000 | -100,026,000 | -239,663,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||
depreciation and amortization | 4,230,000 | 3,253,000 | 3,215,000 | 4,534,000 | 4,581,000 | 4,902,000 | 6,042,000 | 5,395,000 | 5,544,000 | 5,616,000 | 5,730,000 | 4,928,000 | 4,026,000 | 4,039,000 | 4,008,000 | 3,731,000 | 3,794,000 | 3,172,000 |
amortization of deferred contract acquisition costs | 22,841,000 | 21,324,000 | 29,138,000 | 23,559,000 | 20,925,000 | 18,467,000 | 22,643,000 | 21,599,000 | 17,157,000 | 14,072,000 | 21,859,000 | 16,107,000 | 11,038,000 | 10,822,000 | 19,353,000 | 8,933,000 | 6,051,000 | 4,920,000 |
net accretion on marketable securities | -3,332,000 | -3,630,000 | ||||||||||||||||
stock-based compensation expense | 78,006,000 | 76,361,000 | 87,631,000 | 87,488,000 | 94,305,000 | 88,727,000 | 88,930,000 | 95,880,000 | 102,097,000 | 85,048,000 | 99,043,000 | 81,091,000 | 88,252,000 | 101,454,000 | 77,032,000 | 95,103,000 | 92,613,000 | 250,835,000 |
charitable donation of class a common stock | 0 | 4,187,000 | 0 | 0 | 0 | 6,564,000 | 0 | 0 | 0 | 4,215,000 | 0 | 0 | ||||||
non-cash operating lease expense | 5,314,000 | 3,377,000 | 4,137,000 | 4,200,000 | 4,086,000 | 3,476,000 | ||||||||||||
(benefit from) benefit from deferred income taxes | ||||||||||||||||||
other non-cash charges (credits) | -8,764,000 | 12,704,000 | 2,849,000 | |||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||
accounts receivable | -5,039,000 | 197,443,000 | -120,235,000 | -67,719,000 | 3,337,000 | 162,444,000 | -62,710,000 | -149,232,000 | 6,168,000 | 141,557,000 | -90,334,000 | -85,156,000 | -25,157,000 | 76,864,000 | -59,359,000 | -59,989,000 | -3,012,000 | 35,973,000 |
contract assets | -14,054,000 | -9,460,000 | 28,188,000 | -12,406,000 | -12,128,000 | -7,645,000 | 181,000 | -5,420,000 | -10,115,000 | 660,000 | 27,550,000 | -1,589,000 | -7,623,000 | -18,523,000 | -13,666,000 | -9,639,000 | -12,207,000 | -8,148,000 |
deferred contract acquisition costs | -22,348,000 | -13,954,000 | -29,500,000 | -25,759,000 | -21,461,000 | -12,437,000 | -47,106,000 | -35,338,000 | -20,890,000 | -15,499,000 | -49,252,000 | -30,085,000 | -18,811,000 | -20,761,000 | -49,466,000 | -35,774,000 | -24,741,000 | -20,205,000 |
prepaid expenses and other assets | -8,077,000 | -13,074,000 | -3,163,000 | 3,914,000 | 7,117,000 | -803,000 | -13,025,000 | 23,926,000 | -819,000 | -5,860,000 | -32,449,000 | -23,084,000 | 954,000 | -5,231,000 | -13,065,000 | 2,045,000 | -12,006,000 | 7,666,000 |
accounts payable | 3,319,000 | -15,025,000 | 12,902,000 | 8,180,000 | 2,838,000 | 3,936,000 | -10,819,000 | 11,800,000 | -3,903,000 | -2,130,000 | -3,985,000 | -345,000 | -4,795,000 | 7,554,000 | -14,042,000 | 21,212,000 | -3,135,000 | -528,000 |
accrued expenses and other liabilities | 25,489,000 | 12,352,000 | -1,995,000 | 4,212,000 | 11,213,000 | -4,195,000 | -10,505,000 | 26,538,000 | 6,318,000 | -10,547,000 | ||||||||
accrued compensation and employee benefits | 21,180,000 | -72,534,000 | 25,159,000 | 11,212,000 | 36,604,000 | -96,403,000 | 36,551,000 | 33,594,000 | 19,206,000 | -93,390,000 | 41,182,000 | 18,946,000 | 20,041,000 | -65,083,000 | 31,864,000 | 27,747,000 | -60,433,000 | |
operating lease liabilities | -4,266,000 | -2,146,000 | -4,777,000 | -3,767,000 | -3,071,000 | -3,912,000 | -3,294,000 | -2,764,000 | -4,586,000 | -2,946,000 | -2,819,000 | 1,934,000 | -472,000 | -1,950,000 | -3,803,000 | -1,563,000 | -1,891,000 | -1,807,000 |
deferred revenue | -53,496,000 | -60,261,000 | 70,110,000 | 30,111,000 | -7,190,000 | -24,683,000 | 107,346,000 | 59,672,000 | -8,662,000 | -20,885,000 | 106,514,000 | 44,356,000 | 24,165,000 | -14,289,000 | 58,937,000 | 27,307,000 | 14,784,000 | 4,453,000 |
net cash from operating activities | 41,587,000 | 119,002,000 | 146,082,000 | 28,070,000 | 46,376,000 | 100,037,000 | 145,602,000 | 41,854,000 | 44,285,000 | 67,341,000 | 93,957,000 | -27,317,000 | -23,737,000 | -52,884,000 | -6,014,000 | -25,426,000 | -6,001,000 | -17,522,000 |
capex | 0 | -12,832,000 | -7,392,000 | -4,875,000 | -1,418,000 | -1,238,000 | -3,784,000 | -682,000 | -1,006,000 | -1,870,000 | -2,201,000 | -5,316,000 | -6,606,000 | -9,692,000 | -3,160,000 | -2,078,000 | -1,441,000 | -2,200,000 |
free cash flows | 41,587,000 | 106,170,000 | 138,690,000 | 23,195,000 | 44,958,000 | 98,799,000 | 141,818,000 | 41,172,000 | 43,279,000 | 65,471,000 | 91,756,000 | -32,633,000 | -30,343,000 | -62,576,000 | -9,174,000 | -27,504,000 | -7,442,000 | -19,722,000 |
cash flows from investing activities | ||||||||||||||||||
purchases of marketable securities | -146,706,000 | -153,353,000 | -308,112,000 | -464,478,000 | -374,628,000 | -323,137,000 | -479,359,000 | -297,407,000 | -493,808,000 | -215,391,000 | -184,098,000 | -158,711,000 | -23,682,000 | -21,918,000 | -51,298,000 | -67,057,000 | 0 | -94,157,000 |
maturities of marketable securities | 146,051,000 | 111,083,000 | 298,808,000 | 446,439,000 | 370,196,000 | 360,141,000 | 474,504,000 | 237,836,000 | 259,689,000 | 78,955,000 | 58,128,000 | 45,865,000 | 32,620,000 | 14,813,000 | 49,636,000 | 21,504,000 | 12,850,000 | 23,755,000 |
purchases of property and equipment | 0 | -12,832,000 | -7,392,000 | -4,875,000 | -1,418,000 | -1,238,000 | -3,784,000 | -682,000 | -1,006,000 | -1,870,000 | -2,201,000 | -5,316,000 | -6,606,000 | -9,692,000 | -3,160,000 | -2,078,000 | -1,441,000 | -2,200,000 |
payments related to business acquisition, net of cash acquired | 0 | -24,821,000 | ||||||||||||||||
purchases of investments | 0 | 0 | ||||||||||||||||
net cash from investing activities | -655,000 | -79,923,000 | -16,696,000 | -22,914,000 | -41,659,000 | 35,766,000 | -8,639,000 | -60,253,000 | -235,125,000 | -135,552,000 | -126,467,000 | -118,227,000 | -28,752,000 | -15,697,000 | -6,322,000 | -51,041,000 | 11,048,000 | 10,873,000 |
cash flows from financing activities | ||||||||||||||||||
repurchases of class a common stock | -101,576,000 | -227,525,000 | -9,348,000 | -162,651,000 | -196,747,000 | -22,005,000 | -49,966,000 | |||||||||||
proceeds from exercise of stock options | 221,000 | 302,000 | 7,098,000 | 291,000 | 331,000 | 312,000 | 1,319,000 | 1,517,000 | 2,717,000 | 1,187,000 | 783,000 | 2,923,000 | 1,859,000 | 2,823,000 | 2,510,000 | 3,036,000 | 3,537,000 | 3,114,000 |
payments of tax withholdings on net settlement of equity awards | -14,083,000 | -12,195,000 | -17,447,000 | -14,534,000 | -16,990,000 | -28,959,000 | -36,572,000 | -22,663,000 | -26,930,000 | -25,902,000 | -19,795,000 | -14,583,000 | -21,388,000 | -17,329,000 | -167,000 | -746,000 | ||
net (payments) receipts of tax withholdings on sell-to-cover equity award transactions | 652,000 | 0 | ||||||||||||||||
proceeds from employee stock purchase plan contributions | 3,855,000 | 4,214,000 | 2,712,000 | 4,251,000 | 3,726,000 | 4,916,000 | 3,302,000 | 4,610,000 | 4,913,000 | 4,730,000 | 1,486,000 | 5,018,000 | 2,151,000 | 6,356,000 | 5,274,000 | 6,864,000 | ||
payment of deferred consideration related to business acquisition | 0 | 0 | 0 | 0 | ||||||||||||||
net cash from financing activities | -111,602,000 | -235,204,000 | -16,985,000 | -172,643,000 | -215,151,000 | -45,736,000 | -81,917,000 | -69,151,000 | -25,197,000 | -20,630,000 | -16,874,000 | -6,642,000 | -18,966,000 | -18,187,000 | -2,369,000 | 20,089,000 | 9,040,000 | 1,442,913,000 |
effect of exchange rate changes | -1,354,000 | 17,570,000 | -6,835,000 | 1,804,000 | 3,129,000 | -5,127,000 | 3,546,000 | -3,224,000 | -1,241,000 | -1,702,000 | 351,000 | -4,018,000 | -406,000 | -2,738,000 | 7,011,000 | 6,371,000 | 2,570,000 | 2,313,000 |
net decrease in cash, cash equivalents, and restricted cash | 105,566,000 | -165,683,000 | -90,774,000 | |||||||||||||||
cash, cash equivalents, and restricted cash - beginning of period | 0 | 879,634,000 | 0 | 0 | 1,062,116,000 | 0 | 0 | 1,768,723,000 | ||||||||||
cash, cash equivalents, and restricted cash - end of period | -72,024,000 | 701,079,000 | -165,683,000 | -207,305,000 | 1,147,056,000 | -156,204,000 | -71,861,000 | 1,679,217,000 | ||||||||||
supplemental disclosure of cash flow information | ||||||||||||||||||
cash paid for interest | 0 | 0 | 264,000 | 45,000 | 48,000 | 102,000 | 327,000 | 86,000 | -69,000 | 193,000 | 250,000 | 277,000 | 179,000 | 199,000 | 99,000 | 214,000 | ||
cash paid for income taxes | 5,075,000 | 6,052,000 | 1,011,000 | 3,644,000 | 4,663,000 | 7,391,000 | 1,686,000 | 1,902,000 | 1,016,000 | 6,218,000 | 1,939,000 | 1,450,000 | 14,828,000 | 2,782,000 | 1,774,000 | 2,645,000 | 959,000 | 3,076,000 |
supplemental disclosure of non-cash investing and financing activities | ||||||||||||||||||
property and equipment purchases included in accounts payable | -1,000 | 63,000 | 305,000 | 99,000 | 50,000 | 65,000 | ||||||||||||
deferred and contingent consideration recognized in connection with business acquisition | 0 | 9,835,000 | ||||||||||||||||
tax withholdings on net settlement of restricted stock units, accrued but not yet paid | 1,716,000 | 3,136,000 | 381,000 | 224,000 | -235,000 | 4,304,000 | -3,479,000 | 4,367,000 | 470,000 | 1,996,000 | -304,000 | -2,612,000 | -2,470,000 | 7,599,000 | 9,218,000 | |||
benefit from deferred income taxes | 640,000 | -21,525,000 | 183,000 | 569,000 | 1,594,000 | -983,000 | 210,000 | -267,000 | -310,000 | -334,000 | ||||||||
net increase in cash, cash equivalents, and restricted cash | -178,555,000 | 84,940,000 | ||||||||||||||||
cash flows from operating activities: | ||||||||||||||||||
abandonment and impairment charges | 0 | |||||||||||||||||
other non-cash credits | -2,275,000 | |||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||
payments related to business acquisitions, net of cash acquired | 0 | -65,000 | ||||||||||||||||
other investing | 0 | 0 | 0 | 2,754,000 | 1,704,000 | 0 | -1,607,000 | 1,100,000 | ||||||||||
cash flows from financing activities: | ||||||||||||||||||
net receipts (payments) of tax withholdings on sell-to-cover equity award transactions | 0 | 0 | ||||||||||||||||
repurchase of unvested early exercised stock options | 0 | 0 | ||||||||||||||||
cash, cash equivalents, and restricted cash at beginning of period | ||||||||||||||||||
cash, cash equivalents, and restricted cash at end of period | ||||||||||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||
supplemental disclosures of non-cash investing and financing activity: | ||||||||||||||||||
value of shares issued in payment of business acquisitions | 0 | 0 | ||||||||||||||||
loan notes issued in connection with business acquisitions | ||||||||||||||||||
reduction in accrued expenses and other liabilities for vesting of early exercised stock options | 1,000 | 2,000 | 0 | 0 | 1,355,000 | 294,000 | 462,000 | 615,000 | 1,646,000 | |||||||||
purchases of property and equipment included in accounts payable | ||||||||||||||||||
net amortization on marketable securities | -8,025,000 | -9,259,000 | -9,268,000 | -8,690,000 | -8,811,000 | -6,648,000 | -4,097,000 | |||||||||||
payable for marketable securities purchase | -744,000 | |||||||||||||||||
other non-cash (credits) charges | 393,000 | -966,000 | -751,000 | |||||||||||||||
net payments of tax withholdings on sell-to-cover equity award transactions | 34,000 | -34,000 | -645,000 | -10,037,000 | ||||||||||||||
receivable from maturities of marketable securities included in prepaid expense and other current assets | 20,315,000 | |||||||||||||||||
sales of marketable securities | 0 | 0 | 0 | 89,383,000 | ||||||||||||||
capitalized software development costs | ||||||||||||||||||
proceeds from initial public offering, net of underwriting discounts and commissions | 0 | 0 | 0 | 692,369,000 | ||||||||||||||
payments of initial public offering costs | 0 | 0 | -1,328,000 | -2,406,000 | ||||||||||||||
proceeds from issuance of convertible preferred stock | 0 | 0 | 0 | 750,000,000 | ||||||||||||||
issuance costs related to convertible preferred stock | ||||||||||||||||||
stock-based compensation capitalized for software development | 0 | 2,205,000 | 131,000 | 2,151,000 | ||||||||||||||
amortization of operating lease right-of-use assets | 3,364,000 | 3,228,000 | 3,071,000 | 3,120,000 | 3,958,000 | 1,838,000 | 2,759,000 | 2,862,000 | 2,433,000 | |||||||||
cash, cash equivalents and restricted cash - beginning of period | 0 | 0 | 371,190,000 | |||||||||||||||
cash, cash equivalents and restricted cash - end of period | -50,007,000 | 16,657,000 | 1,809,767,000 | |||||||||||||||
other non-cash charges | 624,000 | |||||||||||||||||
net decrease in cash and cash equivalents | -90,543,000 | |||||||||||||||||
cash and cash equivalents - beginning of period | 1,402,119,000 | |||||||||||||||||
cash and cash equivalents - end of period | 1,311,576,000 | |||||||||||||||||
reversal of deferred contract acquisition costs and accrued sales commissions | ||||||||||||||||||
proceeds from credit agreement | ||||||||||||||||||
repayment of credit agreement | ||||||||||||||||||
payment of deferred loan costs related to senior secured credit facility | ||||||||||||||||||
deferred consideration related to business acquisitions | ||||||||||||||||||
property and equipment included in accounts payable | 779,000 | |||||||||||||||||
prior period amounts have been combined to conform to current presentation | ||||||||||||||||||
net amortization of premium on marketable securities | -359,000 | 387,000 | 473,000 | 563,000 | 524,000 | 309,000 | 558,000 | |||||||||||
accrued expense and other liabilities | 722,000 | -1,613,000 | -12,894,000 | 9,272,000 | 3,911,000 | 4,573,000 | ||||||||||||
capitalization of software development costs | -2,179,000 | -361,000 | -410,000 | |||||||||||||||
payments of issuance costs for convertible preferred stock | 0 | 0 | -164,000 | |||||||||||||||
net increase in cash, cash equivalents and restricted cash | -156,204,000 | -71,861,000 | -89,506,000 | -7,694,000 | -50,007,000 | 16,657,000 | 1,438,577,000 | |||||||||||
deferred payments related to business acquisitions | 0 | |||||||||||||||||
impairment of long-lived assets | ||||||||||||||||||
( prior period amounts have been combined to conform to current presentation | ||||||||||||||||||
deferred income taxes | 1,594,000 | -5,475,000 | -223,000 | -155,000 | 21,000 | |||||||||||||
payment related to business acquisition, net of cash acquired | 0 | 0 | -5,498,000 | |||||||||||||||
value of shares issued in payment of business acquisition | 0 | 0 | 21,000 | 30,446,000 | ||||||||||||||
deferred offering costs, accrued but not yet paid | 1,328,000 | |||||||||||||||||
impairment charges on assets | ||||||||||||||||||
accrued compensation and benefits | ||||||||||||||||||
purchases of intangible assets | 0 | |||||||||||||||||
net receipts of tax withholdings on sell-to-cover equity award transactions | -9,986,000 | 10,935,000 | ||||||||||||||||
repurchase and retirement of common stock | ||||||||||||||||||
tax withholdings on net settlement of restricted stock units, accrued and unpaid | -175,000 | -551,000 | ||||||||||||||||
amortization of deferred loan cost | 66,000 | 67,000 | 66,000 | |||||||||||||||
loss on fixed asset disposal | ||||||||||||||||||
(benefit from) benefit from bad debt | 465,000 | 50,000 | -709,000 | |||||||||||||||
benefit from uncertain tax position | ||||||||||||||||||
proceeds from credit facility | ||||||||||||||||||
repayments of credit facility | ||||||||||||||||||
non-cash operating lease costs | 1,734,000 |
We provide you with 20 years of cash flow statements for UiPath . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of UiPath . stock. Explore the full financial landscape of UiPath . stock with our expertly curated income statements.
The information provided in this report about UiPath . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.